MB0201 is a potent probiotic blend that is tailored for pharmaceutical and nutraceutical purposes. Featuring lactobacillus salivarius and limosilactobacillus reuteri, Pharm-Rx MB0201 bolsters digestive health and extends its benefits to enhanced glycemic control and fostering a healthy gut microflora.

Ingredient Name: Probiotic Blend

Functions: Probiotic

Benefit Claims (Health): Anti-Inflammatory, Improves Glycemic Control, Promotes Healthy Gut Microflora

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar

    Enhanced TDS

    Identification & Functionality

    Features & Benefits

    Benefit Claims (Health)
    Product Background
    • Diabetes, a chronic disease with mild early symptoms, often goes undetected for years.
    • Global diabetes prevalence is steadily increasing, projected to reach 10.9% by 2045.
    • Type 2 diabetes, accounting for 90% of cases, is influenced by acquired dietary habits, age, and obesity.
    • In Taiwan, 11.1% of adults have diabetes, with potential complications like stroke, heart disease, and kidney disease posing serious health risks.
    • The gut microbiota plays a vital role in metabolism, and imbalances have been linked to diabetes and inflammatory responses.
    Product Benefits
    • Research center has developed the MB0201 strain combination, comprising Lactobacillus reuteri GL-104 and Lactobacillus salivarius AP-32, specifically for Type 2 diabetes.
    • These strains stabilize blood sugar levels, improve hyperlipidemia symptoms, and possess anti-inflammatory properties, promoting pancreatic β cell health and achieving blood sugar stability.

    Applications & Uses


    Typical Properties
    ValueUnitsTest Method / Conditions
    Viable Microorganisms Count1000 billion CFU/g

    Regulatory & Compliance

    FDA Disclaimer

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.